Andrew McNab - License issues - 10 Apr 2002 License issues for EU DataGrid (on behalf of Anders Wannanen) Andrew McNab, University of Manchester

Slides:



Advertisements
Similar presentations
© 2008 Oracle Corporation – Proprietary and Confidential.
Advertisements

Camager Grid CA Manager Lauri Anton EENet / BalticGrid.
IMPORTANT READ CAREFULLY BEFORE USING THIS PRODUCT LICENSE AGREEMENT AND LIMITED WARRANTY BY INSTALLING OR USING THE SOFTWARE, FILES OR OTHER ELECTRONIC.
© 2006 Hewlett-Packard Development Company, L.P. The information contained herein is subject to change without notice Open Source Software A Commercial.
Jul The New Geant4 License J. Perl The New Geant4 License Makes clear the user’s wide- ranging freedom to use, extend or redistribute Geant4, even.
+ Andrés Guadamuz SCRIPT Centre for Research in IP and Technology Law, Edinburgh, UK Proprietary, Free and Open Source Software (FOSS), and Mixed Platforms.
Content Management Systems …mostly Umbraco ALL ABOUT.
1 EPICS EPICS Licensing BESSY, May 2002 Andrew Johnson.
FPGA and ASIC Technology Comparison - 1 © 2009 Xilinx, Inc. All Rights Reserved How do I Get Started with PlanAhead?
Middleware Promises Warranties that Don’t Indemnities that Won’t Stephen Rubin, Esquire
STATUS UPDATE EM SUBCOMMITTEE Friedrich Roth, EM subcommittee chairman SEG 2012, Las Vegas Technical Standards Committee meeting.
DIRC Workshop on Software Quality and the Legal System 13 February 2004, Gray's Inn, London LEGAL ASPECTS OF SOFTWARE PROCUREMENT Jos Dumortier University.
Anticipated 2008 Generic Launches JULY 2008 David Harding, API Intelligence, Thomson Reuters Source: FDA, NEWPORT HORIZON PREMIUM TM © THOMSON REUTERS.
Adding Genes This presentation gives a quick overview on how to add Genes to Osprey.
X3D Graphics for Web Authors X3D-Edit Update SIGGRAPH 2008 Don Brutzman Naval Postgraduate School Monterey California USA.
17-1 JXTA Developer and Business Resources Module Objectives ● Understand JXTA's Open Source Model ● Learn how to get involved at jxta.org ● Learn.
Blue Diamond Scott Auge Amduus Information Works, Inc.
MESSAGING IN THE MEDIA TOP 10 DRUGS BASED ON CREDIBILITY INDEX IN THE LITERATURE JOHN KNAPP, DIRECTOR OF ANALYTICS MAY 2009 Your use of these materials.
Digital Intuition Cluster, Smart Geometry 2013, Stylianos Dritsas, Mirco Becker, David Kosdruy, Juan Subercaseaux Setup Instructions Overview 1. License.
End User License Agreement Permission to use and redistribute this Document is granted, provided that (1) the below copyright notice appears in all copies.
NRCCL (University of Oslo, Faculty of Law) Copyleft and Open Source Jon Bing Notrwegian Research Center for Computers and Law Master Lecture 13 October.
Hayabusa K2-K7 ECU Reflashing and Engine data Interfaces
Therapeutic area breakdown of lead projects in development for first launch in 2005 APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM ©
Custom Software Development Intellectual Property and Other Key Issues © 2006 Jeffrey W. Nelson and Iowa Department of Justice (Attach G)
Resume Builder Todd Abel, Microsoft Copyright Notice © 2003 Microsoft Corporation. All rights reserved.
CRICOS No J a university for the world real R The OAK Law Project Queensland University of Technology CRICOS No J 1.
Paragraph IV Patent Challenges – As of July 1, 2008 JULY 2008 David Harding, API Intelligence, Thomson Reuters Source: FDA, NEWPORT HORIZON PREMIUM TM.
Proportion of biotech-derived active substances in development for first launch 31st December APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE.
International Telecommunication Union New Delhi, India, December 2011 ITU Workshop on Standards and Intellectual Property Rights (IPR) Issues Philip.
Changing Databases This presentation gives a quick overview on how to change databases in Osprey.
Software Licences HSF Recommendations John Harvey / CERN 24 June 2015
National Alliance for Medical Image Computing Licensing in NAMIC 3 requirements from NCBC RFA (paraphrased)
Oracle Fusion Applications 11gR1 ( ) Functional Overview (L2) Manage Inbound Logistics (L3) Manage Receipts.
Oracle Fusion Applications 11gR1 ( ) Functional Overview (L2) Manage Outbound Logistics (L3) Pick Loads.
Oracle Fusion Applications 11gR1 ( ) Functional Overview (L2) Manage Inbound Logistics (L3) Put Away Loads.
Oracle Fusion Applications 11gR1 ( ) Functional Overview (L2) Manage Inbound Logistics (L3) Manage Supplier Returns.
Proportion of total R&D expenditure by therapeutic area in 2005 APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM © THOMSON REUTERS Your.
Oracle Fusion Applications 11gR1 ( ) Functional Overview (L2) Manage Inbound Logistics (L3) Manage and Disposition Inventory Returns.
Global R&D expenditure, development times, global pharmaceutical sales and new molecular entity output MARCH 2008 SOURCE: CMR INTERNATIONAL.
Oracle Fusion Applications 11gR1 ( ) Functional Overview (L2) Manage Inbound Logistics (L3) Inspect Material.
2005/2006 Expenditure on biotech derived entities had remained constant APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM © THOMSON REUTERS.
Number of pharmaceutical patent applications and granted patents for 5 major patent issuing authorities JUNE 2008 SOURCE: DERWENT WORLD PATENTS.
Adding Interactions This presentation gives a quick overview on how to add interactions into Osprey.
Nomenclature for the OGSA Platform document Fred Maciel.
INTEL CONFIDENTIAL Intel® Smart Connect Technology Remote Wake with WakeMyPC November 2013 – Revision 1.2 CDI/IBP #:
Regulatory approval times between submission and marketing authorization approval APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM.
Availability of High-Quality API for India, China and Rest of World MARCH 2008 David Harding, API Intelligence, Thomson Reuters Source: NEWPORT HORIZON.
1 of 26 For Oracle employees and authorized partners only. Do not distribute to third parties. © 2009 Oracle Corporation – Proprietary and Confidential.
End User License Agreement Permission to use and redistribute this Document is granted, provided that (1) the below copyright notice appears in all copies.
Allocation of R&D expenditure in 2005 between chemical entity and biological or biotech active substances APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE.
-1- For Oracle employees and authorized partners only. Do not distribute to third parties. © 2009 Oracle Corporation – Proprietary and Confidential Oracle.
Ideas about Evolution. Activity 14: Ideas about Evolution LIMITED LICENSE TO MODIFY. These PowerPoint® slides may be modified only by teachers currently.
Permission to reprint or distribute any content from this presentation requires the prior written approval of Standard & Poor’s. Copyright © 2011 Standard.
The secure site rendering issue (all navigation crushed together as a list at the top of the page) is a compatibility issue with Internet Explorer only.
Contributing to or Starting an OS Project What’s in it for your client, and How can you help? Michael Atlass Sr. Director, Legal Counsel Qualcomm Presented.
Copyright © 2012, Oracle and/or its affiliates. All rights reserved. Oracle Proprietary and Confidential. 1.
Connectivity to bank and sample account structure
Open Source Software: Top 10 Myths that Every In-House, Government, & Private Practice Lawyer Should Know 2017 NAPABA Convention Washington, D.C.
Agile
BIOLOGY / CHEMISTRY CITATIONS GROWTH
Comparative Law of Licenses and Contracts in the US, UK and EU
4) Flow control Logical operators, comparative operators Instructions:
Automation in an XML Authoring Environment
Messaging in the Media TOP 10 AUDIENCES BY THERAPY AREA
Proportion of total R&D expenditure on alliances or joint ventures by stage of R&D in 2005 APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM.
Motivation for 36OU Open Rack
APACHE LICENSE HISTORICAL EVOLUTION
BEMS user Manual Fundación cartif.
© Healthcare Inspirations. All rights reserved
2019 MEDICARE AGE-IN STUDY SENIOR MARKET INSIGHTS SERVICE Part IV
Presentation transcript:

Andrew McNab - License issues - 10 Apr 2002 License issues for EU DataGrid (on behalf of Anders Wannanen) Andrew McNab, University of Manchester

Andrew McNab - License issues - 10 Apr 2002 Open Grid License Agreement u Propose to base license on Globus’s “Open Grid License Agreement” u This is essentially the Apache License (part of the BSD license family) plus a clause about implicit granting of rights back to distributors. u The License is GPL compatible, in that portions of EDG code could be incorporated into an existing GPL application and then (necessarily) distributed under the GPL n Several developers have expressed concerns about not shutting out GPL applications u The License is BSD-like, so commercial organisations can use our code to produce their own closed-source products (eg Platform, Microsoft etc) without having to publish the resulting source. n This appears to be necessary for collaboration with some industrial partners.

Andrew McNab - License issues - 10 Apr 2002 OGLA’s wider aims u Minimise overhead in third-parties contributing code. n Provide a clear, legally evaluated license so contributors know where they stand. n Provide license in template form so people starting new (especially small) projects have an “off the shelf” solution. u Maximise take up by simplifying the set of licenses used for Grid software. u Clarify by centralising rights through non-exclusive licenses granted to distributors (eg Globus, EDG)

Andrew McNab - License issues - 10 Apr 2002 Draft License (1/4) u Distributor chooses PROJECT etc and which Optional items to use. u PROJECT: The EU DataGrid u SOFTWARE: The EDG ??Toolkit?? u URL: u NAMES: “EDG”??, “EDG ??Toolkit??” and “the EU DataGrid Project” u u Copyright (c) [YEAR of 1 st RELEASE] – [YEAR OF CURRENT RELEASE] [Name of Copyright Holder]. All rights reserved. u Redistribution and use in source and binary forms, with or without modification, are permitted provided that the following conditions are met: u 1. Redistributions of source code must retain the above copyright notice, this list of conditions and the following disclaimer.

Andrew McNab - License issues - 10 Apr 2002 Draft License (2/4) u 2. Redistributions in binary form must reproduce the above copyright notice, this list of conditions and the following disclaimer in the documentation and/or other materials provided with the distribution. u (Optional) 3. The end-user documentation included with the redistribution, if any, must include the following acknowledgment: "This product includes software developed by the PROJECT (URL)." u Alternately, this acknowledgment may appear in the software itself, if and wherever such third-party acknowledgments normally appear. u (Optional) 4. The names NAMES must not be used to endorse or promote products derived from this software without prior written permission. For written permission, please contact .

Andrew McNab - License issues - 10 Apr 2002 Draft License (3/4) u (Optional) 5. Products derived from this software may not be called NAMES, nor may NAMES appear in their name, without prior written permission of PROJECT. u 6. You are under no obligation whatsoever to provide anyone with any bug fixes, patches, or upgrades to the features, functionality or performance of the Software (“Enhancements”) that you may develop over time; however, if you choose to provide your Enhancements to PROJECT, or if you choose to otherwise publish or distribute your Enhancements, in source code form without contemporaneously requiring end users of PROJECT to enter into a separate written license agreement for such Enhancements, then you hereby grant PROJECT a non-exclusive, royalty-free perpetual license to install, use, copy, modify, prepare derivative works, incorporate into the SOFTWARE or any other computer software, distribute, and sublicense your Enhancements or derivative works thereof, in binary and source code form (if any), whether developed by PROJECT or third parties.

Andrew McNab - License issues - 10 Apr 2002 Draft License (4/4) u THIS SOFTWARE IS PROVIDED "AS IS" AND ANY EXPRESSED OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE ARE DISCLAIMED. IN NO EVENT SHALL PROJECT OR ITS CONTRIBUTORS BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL DAMAGES (INCLUDING, BUT NOT LIMITED TO, PROCUREMENT OF SUBSTITUTE GOODS OR SERVICES; LOSS OF USE, DATA, OR PROFITS; OR BUSINESS INTERRUPTION) HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) ARISING IN ANY WAY OUT OF THE USE OF THIS SOFTWARE, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. u This software consists of voluntary contributions made by many individuals on behalf of the PROJECT. For more information on PROJECT, please see URL.

Andrew McNab - License issues - 10 Apr 2002 Currently outstanding issues u Based on feedback from CERN legal experts: n Implicit licensing of contributions clause (6) does not agree to indemnify EU DataGrid against IP violations by the contributor (eg if they contributed code they have no right to, or which violates patents.) n Some concerns about copyright statements when code from several projects is mixed (However, many open source projects have multiple “Copyright XYZ” lines.) u Discussions ongoing with Ian Foster about synchronisation with Globus.

Andrew McNab - License issues - 10 Apr 2002 Summary u License exists in draft form. u Based on Globus’s proposed Open Grid License Agreement. u Has been checked by CERN legal experts u Some issues raised but overall verdict positive. u Discussion with Ian Foster ongoing.